Journal
LASERS IN SURGERY AND MEDICINE
Volume 38, Issue 5, Pages 445-467Publisher
WILEY
DOI: 10.1002/lsm.20352
Keywords
age related macular degeneration; fluorodeoxyglucose; MRI; PET; PDT
Categories
Funding
- NCI NIH HHS [R21 CA114053, CA55791, P30CA16056, R21 CA109914] Funding Source: Medline
Ask authors/readers for more resources
The purpose of this review is to call attention in the use of chlorophyll-a and bacteriochlorophyll-a to develop more than 600 photosensitizers (lambda(max) 660 nm-800 nm) during the last 15 years (1990-2005) at the Photodynamic Therapy Center, Roswell Park Cancer Institute, Buffalo. This article mainly includes the chemistry, preclinical results, and brief clinical data of some of the most effective photosensitizers. The utility of the tumor-avid photosensitizers in developing multimodality agents (imaging and therapy) is also presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available